"Tetracyclines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117)
| Descriptor ID |
D013754
|
| MeSH Number(s) |
D02.455.426.559.847.562.900 D04.615.562.900
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Tetracyclines".
Below are MeSH descriptors whose meaning is more specific than "Tetracyclines".
This graph shows the total number of publications written about "Tetracyclines" by people in this website by year, and whether "Tetracyclines" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2012 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 6 | 2 | 8 |
| 2019 | 3 | 1 | 4 |
| 2020 | 1 | 1 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Tetracyclines" by people in Profiles.
-
National surveillance of antimicrobial susceptibilities to dalbavancin, telavancin, tedizolid, eravacycline, omadacycline and other comparator antibiotics and serotype distribution of invasive Streptococcus pneumoniae isolates in adults: results from the Surveillance of Multicenter Antimicrobial Resistance in Taiwan (SMART) programme in 2017-2020. J Glob Antimicrob Resist. 2021 09; 26:308-316.
-
The Emerging Role of Epigenetic Mechanisms in the Causation of Aberrant MMP Activity during Human Pathologies and the Use of Medicinal Drugs. Biomolecules. 2021 04 15; 11(4).
-
Concomitant use of dexamethasone and tetracyclines: a potential therapeutic option for the management of severe COVID-19 infection? Expert Rev Clin Pharmacol. 2021 Mar; 14(3):315-322.
-
Repurposing of Tetracyclines for COVID-19 Neurological and Neuropsychiatric Manifestations: A Valid Option to Control SARS-CoV-2-Associated Neuroinflammation? J Neuroimmune Pharmacol. 2021 06; 16(2):213-218.
-
Tetracyclines in COVID-19 patients quarantined at home: Literature evidence supporting real-world data from a multicenter observational study targeting inflammatory and infectious dermatoses. Dermatol Ther. 2021 Jan; 34(1):e14694.
-
Possible treatment and strategies for COVID-19: review and assessment. Eur Rev Med Pharmacol Sci. 2020 12; 24(23):12593-12608.
-
Tetracycline and viruses: a possible treatment for COVID-19? Arch Virol. 2021 Jan; 166(1):1-7.
-
The antibiotic paradox: why companies can't afford to create life-saving drugs. Nature. 2020 08; 584(7821):338-341.
-
Computational insights into tetracyclines as inhibitors against SARS-CoV-2 Mpro via combinatorial molecular simulation calculations. Life Sci. 2020 Sep 15; 257:118080.
-
Prediction of repurposed drugs for treating lung injury in COVID-19. F1000Res. 2020; 9:609.